U.K. researchers believe they've come up with a rapid blood test that could detect sepsis at a patient's bedside, enabling quicker treatment of the severe and sometimes fatal infection.
Med tech giant Agilent has signed a deal with SomaLogic to expand access to that company's protein biomarker discovery platform.
Medtronic has developed a first-of-its-kind implant, pairing traditional deep-brain stimulation with sensing technology, and, after performing its first procedure, the company says the device has a chance to change the standard of care for neurological disorders.
Cancer cells smell, emitting gases laced with biomarkers revealing volatile organic compounds, and, with the right technology, breaking down that odor can help diagnose bladder cancer, according to a study.
Belgian diagnostics outfit MDxHealth has scored $23.5 million through private placement, selling off about 8.7 million shares to expand its commercial abilities and spread the reach of its prostate cancer test.
Navidea is racing to get its beta-amyloid-detecting imaging agent on the market, kicking off enrollment in a Phase III trial for the Alzheimer's-related diagnostic.
In what could be a significant advance toward better treatments for pancreatic cancer--a deadly type of cancer with an overall 5-year survival rate of about 6%-- scientists have developed what they say is the first-of-its-kind human-cell model of the disease.
Researchers from the Medical College of Wisconsin have found that an antioxidant called diapocynin, a synthetic molecule derived from the naturally occurring compound apocynin, was effective at preventing Parkinson's-like symptoms in mice.
Boehringer Ingelheim has stepped in to pick up an option on a preclinical cardiovascular program under development at Stockholm-based Athera Biotechnologies, which is part of Karolinska Development's biotech portfolio.
According to analysts, the Alzheimer's drug market peaked last year at $10.2 billion and will now slide 1.5% per year until 2017, when the cash returns will slide to about $9.5 billion.